Innate immune sensing of cell death in disease and therapeutics

Nat Cell Biol. 2024 Sep;26(9):1420-1433. doi: 10.1038/s41556-024-01491-y. Epub 2024 Sep 2.

Abstract

Innate immunity, cell death and inflammation underpin many aspects of health and disease. Upon sensing pathogens, pathogen-associated molecular patterns or damage-associated molecular patterns, the innate immune system activates lytic, inflammatory cell death, such as pyroptosis and PANoptosis. These genetically defined, regulated cell death pathways not only contribute to the host defence against infectious disease, but also promote pathological manifestations leading to cancer and inflammatory diseases. Our understanding of the underlying mechanisms has grown rapidly in recent years. However, how dying cells, cell corpses and their liberated cytokines, chemokines and inflammatory signalling molecules are further sensed by innate immune cells, and their contribution to further amplify inflammation, trigger antigen presentation and activate adaptive immunity, is less clear. Here, we discuss how pattern-recognition and PANoptosome sensors in innate immune cells recognize and respond to cell-death signatures. We also highlight molecular targets of the innate immune response for potential therapeutic development.

Publication types

  • Review

MeSH terms

  • Animals
  • Cell Death* / immunology
  • Humans
  • Immunity, Innate*
  • Inflammation / immunology
  • Inflammation / pathology
  • Neoplasms / immunology
  • Neoplasms / pathology
  • Neoplasms / therapy
  • Pyroptosis / immunology
  • Receptors, Pattern Recognition / immunology
  • Receptors, Pattern Recognition / metabolism
  • Signal Transduction*

Substances

  • Receptors, Pattern Recognition